Ramos-Fresnedo, Andres
Domingo, Ricardo A.
Perez-Vega, Carlos
Pullen, Michael W.
Akinduro, Oluwaseun O.
Almeida, Joao P.
Jentoft, Mark E.
Bendok, Bernard R.
Chaichana, Kaisorn L.
Trifiletti, Daniel M.
Burns, Terence C.
Porter, Alyx B.
Kizilbash, Sani H.
Middlebrooks, Erik H.
QuiƱones-Hinojosa, Alfredo
Sherman, Wendy J.
Funding for this research was provided by:
FDA (R01FDR07288)
Boston Scientific Corp.
Varian Medical Systems, Inc.
Mayo Clinic Professorship
Clinician Investigator Award
Florida State Department of Health Research Grant
Mayo Clinic Graduate School
NIH (R43CA221490)
Article History
Received: 22 April 2022
Accepted: 17 May 2022
First Online: 14 June 2022
Declarations
:
: EHM serves on an advisory board and receives consulting fees from Boston Scientific Corp. All other authors have no conflict of interest to disclose. The authors declare no competing interests.
: This study was approved by the institutional IRB.
: Written informed consent was obtained from all patients involved in this study.